Korro Bio, Inc. Files 8-K
Ticker: KRRO · Form: 8-K · Filed: Jun 12, 2024 · CIK: 1703647
| Field | Detail |
|---|---|
| Company | Korro Bio, Inc. (KRRO) |
| Form Type | 8-K |
| Filed Date | Jun 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing
TL;DR
Korro Bio (formerly Frequency Therapeutics) filed an 8-K on 6/11/24 for corporate changes.
AI Summary
Korro Bio, Inc. filed an 8-K on June 11, 2024, reporting a change in its corporate structure. The company, formerly known as Frequency Therapeutics, Inc. until April 12, 2017, is incorporated in Delaware and headquartered in Cambridge, MA.
Why It Matters
This filing indicates corporate updates for Korro Bio, Inc., which may affect its operational structure or reporting requirements.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain material financial or operational news.
Key Numbers
- 001-39062 — SEC File Number (Identifies the company's filing with the SEC)
- 47-2324450 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Korro Bio, Inc. (company) — Registrant
- Frequency Therapeutics, Inc. (company) — Former company name
- June 11, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Cambridge, MA (location) — Business address
FAQ
What specific corporate changes are being reported by Korro Bio, Inc. in this 8-K filing?
The filing indicates amendments to articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits, suggesting structural or governance updates.
When was Korro Bio, Inc. previously known as Frequency Therapeutics, Inc.?
The company's name was changed from Frequency Therapeutics, Inc. on April 12, 2017.
What is Korro Bio, Inc.'s primary business classification according to the filing?
Korro Bio, Inc. is classified under Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.
Where is Korro Bio, Inc. headquartered?
Korro Bio, Inc. is headquartered at One Kendall Square, Building 600-700, Suite 6-401, Cambridge, MA 02139.
What is the SEC file number for Korro Bio, Inc.?
The SEC file number for Korro Bio, Inc. is 001-39062.
Filing Stats: 721 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-06-12 16:05:31
Key Financial Figures
- $0.001 — ich registered Common stock, par value $0.001 per share KRRO The Nasdaq Capital M
Filing Documents
- d844802d8k.htm (8-K) — 37KB
- d844802dex31.htm (EX-3.1) — 7KB
- 0001193125-24-159933.txt ( ) — 179KB
- krro-20240611.xsd (EX-101.SCH) — 3KB
- krro-20240611_lab.xml (EX-101.LAB) — 20KB
- krro-20240611_pre.xml (EX-101.PRE) — 12KB
- d844802d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 3.1 Certificate of Amendment of the Restated Certificate of Incorporation, as amended, of Korro Bio, Inc. 104 Cover Page Interactive Data File (Embedded within the Inline XBRL Document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. KORRO BIO, INC. Date: June 12, 2024 By: /s/ Ram Aiyar Name: Ram Aiyar, Ph.D. Title: President and Chief Officer